TY  - GEN
AU  - Pohl,M
AU  - Werner,N
AU  - Munding,J
AU  - Tannapfel,A
AU  - Graeven,U
AU  - Nickenig,G
AU  - Schmiegel,W
AU  - Reinacher-Schick,A
TI  - Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature
SN  - 1439-7803
PY  - 2012///0322
KW  - AC133 Antigen
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antigens, CD
KW  - blood
KW  - Antigens, CD34
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Biomarkers
KW  - Cell Count
KW  - Colorectal Neoplasms
KW  - blood supply
KW  - Disease Progression
KW  - Endothelial Cells
KW  - drug effects
KW  - Endothelium, Vascular
KW  - Female
KW  - Flow Cytometry
KW  - Glycoproteins
KW  - Humans
KW  - Immunohistochemistry
KW  - Male
KW  - Middle Aged
KW  - Peptides
KW  - Pilot Projects
KW  - Stem Cells
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Vascular Endothelial Growth Factor Receptor-2
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1055/s-0031-1281752
ER  -